3-methoxy-9-oxo-9H-indeno[1,2-b]pyrazine-2-carbonitrile

ID: ALA4438288

Chembl Id: CHEMBL4438288

PubChem CID: 16065353

Max Phase: Preclinical

Molecular Formula: C13H7N3O2

Molecular Weight: 237.22

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1nc2c(nc1C#N)C(=O)c1ccccc1-2

Standard InChI:  InChI=1S/C13H7N3O2/c1-18-13-9(6-14)15-11-10(16-13)7-4-2-3-5-8(7)12(11)17/h2-5H,1H3

Standard InChI Key:  NIMDHPBOPNWALH-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

NQO1 Tchem Quinone reductase 1 (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
USP7 Tchem Ubiquitin carboxyl-terminal hydrolase 7 (837 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
USP47 Tchem Ubiquitin carboxyl-terminal hydrolase 47 (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
USP8 Tchem Ubiquitin carboxyl-terminal hydrolase 8 (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 237.22Molecular Weight (Monoisotopic): 237.0538AlogP: 1.57#Rotatable Bonds: 1
Polar Surface Area: 75.87Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.12CX LogD: 2.12
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: -0.58

References

1. Wu X, Li X, Li Z, Yu Y, You Q, Zhang X..  (2018)  Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.,  61  (24): [PMID:30508483] [10.1021/acs.jmedchem.8b01424]
2. Li P, Liu HM..  (2020)  Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.,  191  [PMID:32092586] [10.1016/j.ejmech.2020.112107]

Source